401(k) · DOL Form 5500 · 2023

Theravance Biopharma U.S., Inc. 401(k) Plan

Data updated 2026-08-25

$75M
Total assets Below avg plan size
107
Participants Small participant base
89th
Percentile by assets National rank
$702,409
Avg per participant High balance/head
PlainRetire home → About this data RSS: change history

Official DOL plan name: Theravance Biopharma U.S., Inc. 401(k) Plan · Sponsored by Theravance Biopharma U.S., Inc. · California · Professional & Technical Services

$75M in assets, 107 participants

Theravance Biopharma U.S., Inc.'s Theravance Biopharma U.S., Inc. 401(k) Plan reported $75M in total assets and 107 participants in its 2023 DOL Form 5500 filing, ranking in the 89th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • #18,375 in Professional & Technical Services (20,321 peers)

Coverage in California

Theravance Biopharma U.S., Inc. 401(k) Plan covers 107 participants in California, about 17% of the average California filer (state average ~630 per filing). Assets: $75M.

#18,375
in Professional & Technical Services (20,321 peers)
+14.0%
assets growth YoY
0.8×
vs typical plan assets (national mean)

Theravance Biopharma U.S., Inc. 401(k) Plan's outsized position by total assets

Theravance Biopharma U.S., Inc. 401(k) Plan vs every filed plan by assets

End-of-year total assets · plan year 2023 · DOL Form 5500

$75,157,740 Top 11% higher than 89% of 127,068 filed plans

This plan $0 $2,050,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2023

Theravance Biopharma U.S., Inc. 401(k) Plan among mid-size filed plans by headcount

Plan-year 2023 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Theravance Biopharma U.S., Inc. 401(k) Plan sits mid-pack in the medium band (107 participants).

What changed between DOL Form 5500 filings

plan year 2022 → plan year 2023

  • Theravance Biopharma U.S., Inc. 401(k) Plan reported net income rose from -$23M in the plan year 2022 filing to $9M in the plan year 2023 filing.
  • Theravance Biopharma U.S., Inc. 401(k) Plan reported participants fell from 151 in the plan year 2022 filing to 107 in the plan year 2023 filing.
  • Theravance Biopharma U.S., Inc. 401(k) Plan end-of-year assets rose from $66M in the plan year 2022 filing to $75M in the plan year 2023 filing.

See the national 2022→2023 release diff →

Plan-year Form 5500 strip

Filing strip 463451245 · Theravance Biopharma U.S., Inc. PY 2023 · 401(k)

Theravance Biopharma U.S., Inc. 401(k) Plan · $75M · 107 · 89th

  • SCH $75M
  • SCH 107
  • SCH 89th
  • SCH 401(k)
  • SCH near Byline Bancorp, Inc. 401(k) Plan
  • SCH ind #18375

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Professional & Technical Services retirement plans → · Plans in California →

Theravance Biopharma U.S., Inc. 401(k) Plan in the asset neighbourhood

Altarum Institute Retirement & Savings PlanAltarum Institute Retirement…$75MTheravance Biopharma U.S., Inc. 401(k) PlanTheravance Biopharma U.S., I…$75MByline Bancorp, Inc. 401(k) PlanByline Bancorp, Inc. 401(k) …$75MMimedx Group, Inc. 401(k) PlanMimedx Group, Inc. 401(k) Pl…$75MDpt Laboratories, Ltd. 401(k) PlanDpt Laboratories, Ltd. 401(k…$75M
End-of-year total assets ($M) among Theravance Biopharma U.S., Inc. 401(k) Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2023.

California filing particulars

Total Assets (Beginning of Year)$66M
Net Assets (End of Year)$75M
Net Income$9M
Employer EIN463451245
Plan Effective Date1997-06-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Theravance Biopharma U.S., Inc.)

Sponsor-wide plan assets over time

All Theravance Biopharma U.S., Inc. plans reported in each filing year

Latest sponsor-wide plan assets
$82M 24.43198647022241% vs 2022
2024 filing year
$60M$65M$70M$75M$80M$85M 202220232024 $65.9M $82M ▲ +24.4%
Year Plans Participants Total Assets
2022 1 151 $66M
2023 1 107 $75M
2024 1 95 $82M

Nearby 401(k) Plans in California

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Theravance Biopharma U.S., Inc. 401(k) Plan vs. nearby 401(k) plans in California, assets vs. participants Scatter plot of 6 data points. -50000050000100000150000200000250000 -200204060 Total assets ($B) Participants Theravance Biopharma U.S., Inc. 401(k) Plan, Total assets ($B): 0.07515774 · Participants: 107Theravance Biopharma U.S., Inc. 401(k) PlanWells Fargo & Company 401(k) Plan, Total assets ($B): 51.831350351 · Participants: 193919Wells Fargo & Company 401(k) PlanGoogle LLC 401(k) Savings Plan, Total assets ($B): 39.047152408 · Participants: 122867Google LLC 401(k) Savings PlanOracle Corporation 401(k) Savings and Investment Plan, Total assets ($B): 26.320437734 · Participants: 63105Oracle Corporation 401(k) Savings and Investment PlanIntel 401(k) Savings Plan, Total assets ($B): 22.17918189 · Participants: 59863Intel 401(k) Savings PlanApple 401(k) Plan, Total assets ($B): 19.779511539 · Participants: 106111Apple 401(k) Plan
Theravance Biopharma U.S., Inc. 401(k) Plan vs. nearby 401(k) plans in California, assets vs. participants
Compare Theravance Biopharma U.S., Inc. 401(k) Plan side-by-side with 3 peers →

Theravance Biopharma U.S., Inc. 401(k) Plan's out-of-state 401(k) peers by assets and headcount

Outside California, the nearest 401(k) by assets is Byline Bancorp, Inc. 401(k) Plan in IL ($75M); by covered participants it is Northern Architectural Systems, Inc. 401(k) Plan in NJ (107 participants). Same-state nearby plans are listed separately above.

Closest by plan assets

Nearest other-state filings by tot_assets_eoy ($75M here).

Similar participant headcount

Nearest other-state filings by covered participants (107 participants); asset peers above are excluded.

DOL Form 5500 plan year 2023. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Theravance Biopharma U.S., Inc. 401(k) Plan assets move in 2023? ▼
Theravance Biopharma U.S., Inc. 401(k) Plan grew at a solid clip - up 14.0% during 2023, from $66M to $75M. Reported net income was $9M.
How have Theravance Biopharma U.S., Inc. plan assets changed over time? ▼
Across 3 plan years on file (2022-2024), Theravance Biopharma U.S., Inc.'s sponsor-wide assets grew 24.4%, from $66M to $82M.
Where does Theravance Biopharma U.S., Inc. 401(k) Plan rank by assets among Form 5500 filers? ▼
Theravance Biopharma U.S., Inc. 401(k) Plan ranks in the 89th percentile by end-of-year assets among 127,072 plans that reported assets for plan year 2023 (in the top quartile of all filed plans by assets).
Which 401(k) plans are similar in size to Theravance Biopharma U.S., Inc. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by assets is Byline Bancorp, Inc. 401(k) Plan in IL ($75M, 1,084 participants).
Which 401(k) plans cover a similar participant headcount to Theravance Biopharma U.S., Inc. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by covered participants is Northern Architectural Systems, Inc. 401(k) Plan in NJ (107 participants, N/A in assets).

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 463451245.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.